Secondary analysis results from VAYHIT3, a phase 2 study of ianalumab in patients with primary immune thrombocytopenia previously treated with at least two lines of therapy

Choi P., Bradbury C., Gonzalez-Lopez T. J., AR M. C., Trautmann-Grill K., Rummel M., ...Daha Fazla

BLOOD, cilt.146, ss.844-845, 2025 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 146
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1182/blood-2025-844
  • Dergi Adı: BLOOD
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, EMBASE, Nature Index
  • Sayfa Sayıları: ss.844-845
  • İstanbul Üniversitesi Adresli: Hayır